{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Angiogenesis > Brivanib alaninateCAS：649735-63-7
Molecular Formula：C22H24FN5O4
Molecular Weight：441.46
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to brown Solid
Qty：
Size：
| CAS | 649735-63-7 |
| Name | Brivanib alaninate |
| Molecular Formula | C22H24FN5O4 |
| Molecular Weight | 441.46 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | White to brown Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD22577162 |
| SMILES | O=C(O[C@@H](COC1=CN2C(C(OC3=C(C4=C(NC(C)=C4)C=C3)F)=NC=N2)=C1C)C)[C@@H](N)C |
| Target Point | VEGFR2/KDR/Flk-1;FGFR1 |
| Passage | Angiogenesis;Protein Tyrosine Kinase/RTK |
| Background | Brivanib alaninate is an ATP-competitive VEGFR2 inhibitor. |
| Data Literature Source | [1] Bhide RS，et al. J Med Chem，2006，49(7)，2143-2146. [2] Huynh H，et al. Clin Cancer Res，2008，14(19)，6146-6153. [3] Cai ZW，et al. J Med Chem，2008 ，51(6)，1976-1980. [4] Ayers M，et al. Cancer Res，2007，67(14)，6899-6906. |
| Unit | Bottle |
| Specification | 2mg 5mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
